Novartis Acquires Rights to GSK's Ofatumumab Drug For Multiple Sclerosis Treatment
The Swiss pharma will handle the worldwide development and commercialization of the drug - Ofatumumab - for use in multiple sclerosis, sources said.
The Swiss pharma will handle the worldwide development and commercialization of the drug - Ofatumumab - for use in multiple sclerosis, sources said.
Source-Medindia
Novartis' Oxytocin Nasal Spray can Help Men Reduce Calorie Intake
A new study has revealed that Novartis' oxytocin nasal spray, a synthetic nasal formulation of the love hormone, can help men eat fewer calories.
A new study has revealed that Novartis' oxytocin nasal spray, a synthetic nasal formulation of the love hormone, can help men eat fewer calories.
Young Blood to Cure Decline of Aging Brain
A research showed that injections of juvenile mouse blood boosts learning and memory in older rodents, findings that hold the long-sought cure for the decline of ageing brain.
A research showed that injections of juvenile mouse blood boosts learning and memory in older rodents, findings that hold the long-sought cure for the decline of ageing brain.
Brain Protein Could be Targeted to Slow Alzheimer�s, Study Reveals
A protein that is involved in limiting flexibility in the aging brain could be targeted by new treatments which can slow the progression of Alzheimer’s disease.
A protein that is involved in limiting flexibility in the aging brain could be targeted by new treatments which can slow the progression of Alzheimer’s disease.
